Physician profile
Michael P Donovan
NPI 1942208921
$1,878.61
in general payments reported to CMS, 2019-2025
24 companies · $551 in 2025
The $551 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $468 · 2020: $13.76 · 2021: $48.47 · 2022: $233 · 2023: $331 · 2024: $233 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,025 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,024.60 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $300.40 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $195.59 | 2019-2025 | Erleada |
| Neotract INC. | $184.20 | 2019 | |
| Histosonics, INC. | $148.89 | 2025 | |
| Healthtronics Stone Solutions, LLC | $124.69 | 2025 | Dornier Medtech, Dornier Medtech, Cvac Aspiration System |
| Abbvie INC. | $94.00 | 2022-2024 | Botox |
| Antares Pharma, INC. | $84.34 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Dendreon Pharmaceuticals LLC | $81.56 | 2019-2025 | Provenge |
| Edap Technomed INC | $75.00 | 2024 | |
| Endo USA, INC. | $71.87 | 2025 | Xiaflex, Aveed |
| Blue Earth Diagnostics | $67.66 | 2019 | |
| Laborie Medical Technologies Corp. | $67.30 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Pfizer INC. | $59.32 | 2019-2020 | |
| Boston Scientific Corporation | $43.01 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $41.55 | 2022-2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Ih Ab | $35.63 | 2024 | Lofric |
| Myriad Genetic Laboratories, INC. | $35.53 | 2022-2023 | Prolaris |
| Bioprotect Medical, INC. | $31.94 | 2024 | Bioprotect Balloon Implant System |
| Urogen Pharma, INC. | $28.57 | 2022 | |
| Coloplast Corp | $25.03 | 2022 | |
| Halozyme INC | $23.78 | 2023 | |
| Axonics, INC. | $20.81 | 2023 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $20.44 | 2025 | Gemtesa |
| Allergan, INC. | $17.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Donovan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.